| scholarly article | Q13442814 |
| P2093 | author name string | Mindie H Nguyen | |
| Nghia H Nguyen | |||
| Philip Vutien | |||
| Joseph Hoang | |||
| Louis Brooks | |||
| P2860 | cites work | Ethnic and cultural determinants influence risk assessment for hepatitis C acquisition | Q47333581 |
| Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study. | Q53036392 | ||
| Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010 | Q64128181 | ||
| Hepatitis C | Q74751759 | ||
| Natural history of hepatitis C | Q27000737 | ||
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites | Q34323105 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| Rate and predictors of treatment prescription for hepatitis C. | Q35761383 | ||
| Methods for evaluation of medication adherence and persistence using automated databases | Q36412470 | ||
| Racial differences in hepatitis C treatment eligibility | Q37077462 | ||
| High proportion of hepatitis C virus in community Asian American patients with non-liver-related complaints | Q38054463 | ||
| Systematic review: Asian patients with chronic hepatitis C infection | Q38096012 | ||
| Treatment of chronic HCV with sofosbuvir and simeprevir in patients with cirrhosis and contraindications to interferon and/or ribavirin | Q41087896 | ||
| Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis | Q41110938 | ||
| Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir | Q41142938 | ||
| Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study | Q41256468 | ||
| Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial | Q41613250 | ||
| Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans | Q42203327 | ||
| All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection | Q42238837 | ||
| Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection | Q42258200 | ||
| Less-established risk factors are common in Asian Americans with hepatitis C virus: a case-controlled study | Q42265655 | ||
| Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trial | Q42980412 | ||
| Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6. | Q42993494 | ||
| Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C. | Q43244698 | ||
| Gaps in the achievement of effectiveness of HCV treatment in national VA practice | Q43879719 | ||
| Population-based hepatitis C surveillance and treatment in a national managed care organization. | Q44104984 | ||
| Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients | Q44393867 | ||
| Racial and socioeconomic disparities in access to primary care among people with chronic conditions | Q44450662 | ||
| Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. | Q46038653 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| chronic hepatitis C | Q55779873 | ||
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | e3719 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United States | |
| P478 | volume | 95 |
| Q39309854 | Assessing health-related resiliency in HIV+ Latin women: Preliminary psychometric findings |
| Q47553765 | Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience |
| Q47583932 | Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States. |
| Q91899720 | Disparities in Hepatitis C Linkage to Care in the Direct Acting Antiviral Era: Findings From a Referral Clinic With an Embedded Nurse Navigator Model |
| Q45325975 | Editorial: hepatitis C virus (HCV) disease progression - HCV cure and the elimination of the "ethnic slope". Authors' reply. |
| Q54945179 | Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010. |
| Q90093635 | Evaluating the promise of inclusion of African ancestry populations in genomics |
| Q90095540 | Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016 |
| Q57445746 | Hepatitis C Within a Single Health System: Progression Along the Cascade to Cure Is Higher for Those With Substance Misuse When Linked to a Clinic With Embedded Support Services |
| Q38635796 | Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era. |
| Q59352236 | Race and Hepatitis C Care Continuum in an Underserved Birth Cohort |
| Q40064478 | Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis |
| Q63246355 | The health equity implementation framework: proposal and preliminary study of hepatitis C virus treatment |
| Q38982462 | The impact of hepatitis C virus outside the liver: Evidence from Asia. |
Search more.